Alternatively, the M2 phenotype is stimulated by other factors, such as peroxisome proliferator-activated receptor γ (PPARγ), or pioglitazone, an agonist of PPARγ, which resulted in a protective effect against aneurysms in mice [37,38]. Here, PPARG is linked to aneurysm.